Novavax NVAX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 85%-8.5pp | 93.5%+1.7pp | 91.8%+3.5pp | 88.3%+0.8pp | 87.4%+17.2pp | |
| Operating margin | -13.1%-53.4pp | 40.3%+11.4pp | 28.9%-3.7pp | 32.6%-0.2pp | 32.8%+69.3pp | |
| Net margin | -14.7%-53.9pp | 39.2%+7.1pp | 32.1%-7.1pp | 39.2%+1.1pp | 38.1%+65.6pp | |
| EBITDA margin | -9.4%-52.1pp | 42.8%+10.6pp | 32.2%-4.2pp | 36.4%+0.1pp | 36.3%+65.7pp | |
| Returns | ||||||
| Return on assets | -7.5%-39.7pp | 32.2%+8.5pp | 23.6%-3.2pp | 26.8%-9.4pp | 36.2%+47.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.3× | 0.8×+0.1× | 0.7×+0.1× | 0.7×-0.3× | 0.9×+0.5× | |
| Inventory turnover | 8.3×+1.1× | 7.2×-0.7× | 7.9×-5.1× | 13.1×+0.9× | 12.1×+4.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×+0.4× | 2.1×-0.1× | 2.3×-0.1× | 2.4×+0.3× | 2.1×+1.1× | |
| Quick ratio | 2.5×+0.3× | 2.1×-0.1× | 2.2×-0.1× | 2.3×+0.3× | 2×+1.1× | |
| Cash ratio | 0.7×+0.1× | 0.5×-0.1× | 0.6×0.0× | 0.7×0.0× | 0.6×+0.2× | |
| Leverage | ||||||
| Debt-to-assets | 0.3×0.0× | 0.2×+0.2× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -3.6×-23.7× | 20.1×+7.4× | 12.6×-2.6× | 15.2×-3.7× | 19×+31.4× | |
| Per Share | ||||||
| Book value per share | -$0.89-20.1% | -$0.74+23.5% | -$0.97-555% | $0.21+150% | -$0.43+89.6% | |
| Valuation | ||||||
| Market capitalization | $1.41B+35.6% | $1.09B-22.5% | $1.41B+34.0% | $1.05B+2.0% | $1.03B-19.9% | |
| Enterprise value | $1.47B+76.9% | $1.13B-1.4% | $1.15B+34.2% | $855.37M+3.5% | $826.21M-3.8% | |
| Price / sales | 2.4×+1.5× | 1×-0.4× | 1.3×+0.3× | 1×+0.2× | 0.8×-1.1× | |
| EV / sales | 2.5×+1.8× | 1×-0.1× | 1.1×+0.3× | 0.8×+0.1× | 0.7×-0.6× | |
| Earnings yield | -6.2%-52.3pp | 40.3%+16.1pp | 24.3%-16.0pp | 40.2%-6.2pp | 46.4%+61.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Novavax's profit margins?
- Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
- Where do Novavax's ratios come from?
- Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
